Centre for Pharmacoepidemiology

The Centre for Pharmacoepidemiology (CPE) was established in 2005, with the explicit purpose to create a centre of academic excellence in pharmacoepidemiology, to meet the demands from stakeholders in society and industry for expertise and consultation in this field. The centre, which is still evolving, has since its start met the growing demands, both nationally and internationally, for data on drug safety, drug utilization and rational drug use, including pharmacogenetics.

News

Events Archive

Congratulations to CPE’s three masters students

Congratulations to CPE’s three masters students

From left to right:

Chaitra Srinivas (Master's Programme in Public Health Sciences – Epidemiology), Lamya Abdi (Masters of Global Health), Liwei Zhao (Master's Programme in Public Health Sciences - Epidemiology)

 

Chaitra Srinivas Thesis title: Risk of infections and major adverse cardiovascular events among individuals with psoriasis in Sweden: A nationwide cohort study comparing secukinumab to ustekinumab

Supervisors: Marie Linder and Ingvild Odsbu

Lamya Abdi Thesis title: Antidiabetic medication use for treatment of gestational diabetes mellitus and obstetric complications in Sweden

Supervisors: Carolyn Cesta and  Laura Pazzagli

Liwei Zhao Thesis title: Discontinuation of Insulin in Women with Pre-existing Diabetes During Pregnancy in Sweden: The Role of Socioeconomic Factors

Supervisors: Laura Pazzagli and Carolyn Cesta